Internal Medicine, Gastroenterology · La Jolla, CA
NPI
1124082748
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
10666 N Torrey Pines Rd
La Jolla, CA, 92037
Phone (858) 554-8880
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
698 services
Medicare patients, 2024
310
Average age 73
Drug cost, 2024
$1.1M
796 prescriptions
Company payments, 2025
$107K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul J Pockros was code G0500 (moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito), 157 times for 155 patients. In total Paul J Pockros billed 698 services in 24 codes, and Medicare paid $53K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-06-29.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 157 | 155 | $4.67 | $733 |
| 99214 Office E&M - Established | Office | 131 | 112 | $100.42 | $13K |
| 91200 Standard X-ray | Office | 90 | 82 | $23.67 | $2,131 |
| 45385 Colonoscopy - Lesion Removal | Facility | 79 | 79 | $209.33 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 40 | 39 | $13.16 | $527 |
| 99213 Office E&M - Established | Office | 36 | 35 | $52.17 | $1,878 |
| 43235 Upper GI Endoscopy | Facility | 26 | 25 | $82.86 | $2,154 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 23 | 23 | $185.46 | $4,266 |
| 45380 Lower GI Endoscopy - Other | Facility | 21 | 21 | $88.17 | $1,852 |
| 43239 Upper GI Endoscopy | Facility | 20 | 20 | $76.92 | $1,538 |
| 99204 Office E&M - New | Office | 18 | 18 | $120.68 | $2,172 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 17 | 17 | $185.76 | $3,158 |
| 99203 Office E&M - New | Office | 14 | 14 | $80.87 | $1,132 |
By year: 2022 $45K for 559 services; 2023 $45K for 561 services; 2024 $53K for 698 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul J Pockros prescribed most often to Medicare patients was Ursodiol, with 214 prescriptions and refills. In total Paul J Pockros wrote 796 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ursodiol Generic | 214 | 437 | 51 | $42K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 97 | 97 | 95 | $6,445 |
| Vemlidy Tenofovir Alafenamide | 86 | 102 | 11 | $143K |
| Azathioprine Generic | 74 | 156 | 17 | $2,950 |
| Ocaliva Obeticholic Acid | 49 | 49 | Under 11 | $458K |
| Prednisone Generic | 24 | 58 | Under 11 | $168 |
| Xifaxan Rifaximin | 20 | 20 | Under 11 | $64K |
| Entecavir Generic | 19 | 55 | Under 11 | $1,319 |
| Omeprazole Generic | 19 | 53 | Under 11 | $225 |
| Pantoprazole Sodium Generic | 19 | 43 | Under 11 | $349 |
| Carvedilol Generic | 19 | 35 | Under 11 | $86.64 |
| Livdelzi Seladelpar Lysine | 17 | 17 | Under 11 | $216K |
| Mycophenolate Mofetil Generic | 13 | 23 | Under 11 | $861 |
| Spironolactone Generic | 12 | 34 | Under 11 | $185 |
| Eliquis Apixaban | 12 | 12 | Under 11 | $7,234 |
Brand drugs: 232 claims; generic drugs: 564 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul J Pockros $107K ($107K in general payments such as food, travel and fees) from 17 companies. The largest payer was Intercept Pharmaceuticals, Inc. with $31K.
| Company | Payments | Amount |
|---|---|---|
| Intercept Pharmaceuticals, Inc. | 2 | $31K |
| Gilead Sciences, Inc. GILD | 23 | $23K |
| Novo Nordisk Inc NVO | 9 | $19K |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 16 | $19K |
| Madrigal Pharmaceuticals MDGL | 14 | $10K |
| Mirum Pharmaceuticals, Inc. MIRM | 1 | $3,250 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $647 |
| Abbvie Inc. ABBV | 12 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $102 |
| Mallinckrodt Hospital Products Inc. | 1 | $79.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.